Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Micro-X Ltd. ( (AU:MX1) ) has provided an announcement.
Micro-X Ltd has reported significant achievements for the quarter ending September 2025, including securing its largest order to date with a $3.3 million purchase from the Malaysian Ministry of Health for Rover Plus units. This order marks a strategic expansion into Southeast Asia and highlights the company’s growing momentum in the healthcare market. Additionally, Micro-X is advancing its Head CT technology for stroke diagnosis, with upcoming trials in Australian hospitals and a world-first deployment in ambulances, supported by a $4.4 million government grant. These developments underscore Micro-X’s commitment to expanding its market presence and enhancing its product offerings.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Ltd is an Australian hi-tech company specializing in cold cathode x-ray technology, serving global health and security markets. The company focuses on innovative imaging solutions, including mobile x-ray units and CT scanners, targeting healthcare and security sectors.
Average Trading Volume: 511,699
Technical Sentiment Signal: Hold
Current Market Cap: A$70.12M
For a thorough assessment of MX1 stock, go to TipRanks’ Stock Analysis page.